Response Evaluation Criteria for Solid Tumours (RECIST) were introduced in 2000 to provide a standardized method for assessing response to treatments. The RECIST Working Group has updated RECIST to Version 1.1.
Response Evaluation Criteria for Solid Tumours (RECIST) were introduced in 2000 to provide a standardized method for assessing response to treatments [1] . The RECIST Working Group has updated RECIST to Version 1.1 [2] . The revised version has maintained assessment of tumour burden using the sum of the diameters and continues to use uni-dimensional measurements. The response categories are still complete response, partial response (30% decrease in sum from baseline), stable disease and progressive disease (20% increase in sum from nadir). The revisions address issues that have arisen related to the use of the criteria in clinical practice. Table 1 outlines the main changes. 
